Literature DB >> 16987645

Clinical review: idiopathic pulmonary fibrosis--past, present and future.

Owen J Dempsey1.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is an important, and devastating, interstitial lung disease. It has a median mortality of only 3 years, worse than many cancers, and its incidence continues to rise. In this article, an overview of key developments in our understanding and clinical management of IPF will be provided.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16987645     DOI： 10.1016/j.rmed.2006.08.017

Source DB:  PubMed          Journal:  Respir Med        ISSN： 0954-6111            Impact factor:   3.415


  11 in total

1.  NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts.

Authors:  Nadia Amara; Delphine Goven; Fabienne Prost; Rachel Muloway; Bruno Crestani; Jorge Boczkowski
Journal:  Thorax       Date:  2010-08       Impact factor: 9.139

2.  Plumbagin attenuates Bleomycin-induced lung fibrosis in mice.

Authors:  Saber Mehdizadeh; Marjan Taherian; Paria Bayati; Kazem Mousavizadeh; Salar Pashangzadeh; Ali Anisian; Nazanin Mojtabavi
Journal:  Allergy Asthma Clin Immunol       Date:  2022-10-21       Impact factor: 3.373

3.  Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis.

Authors:  Corrine R Kliment; Judson M Englert; Bernadette R Gochuico; Guoying Yu; Naftali Kaminski; Ivan Rosas; Tim D Oury
Journal:  J Biol Chem       Date:  2008-12-09       Impact factor: 5.157

4.  Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A(4) synthetic analog.

Authors:  Rafael F Guilherme; Debora G Xisto; Steven L Kunkel; Célio G Freire-de-Lima; Patricia R M Rocco; Josiane S Neves; Iolanda M Fierro; Claudio Canetti; Claudia F Benjamim
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

5.  Mast cells: a pivotal role in pulmonary fibrosis.

Authors:  Arul Veerappan; Nathan J O'Connor; Jacqueline Brazin; Alicia C Reid; Albert Jung; David McGee; Barbara Summers; Dascher Branch-Elliman; Brendon Stiles; Stefan Worgall; Robert J Kaner; Randi B Silver
Journal:  DNA Cell Biol       Date:  2013-04       Impact factor: 3.311

6.  Fine crackles on chest auscultation in the early diagnosis of idiopathic pulmonary fibrosis: a prospective cohort study.

Authors:  Onofre Moran-Mendoza; Thomas Ritchie; Sharina Aldhaheri
Journal:  BMJ Open Respir Res       Date:  2021-07

Review 7.  Are mast cells instrumental for fibrotic diseases?

Authors:  Catherine Overed-Sayer; Laura Rapley; Tomas Mustelin; Deborah L Clarke
Journal:  Front Pharmacol       Date:  2014-01-21       Impact factor: 5.810

8.  Immunohistochemical and morphometric evaluation of COX 1 and COX-2 in the remodeled lung in idiopathic pulmonary fibrosis and systemic sclerosis.

Authors:  Edwin Roger Parra; Flavia Lin; Vanessa Martins; Maristela Peres Rangel; Vera Luiza Capelozzi
Journal:  J Bras Pneumol       Date:  2013 Nov-Dec       Impact factor: 2.624

9.  17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice.

Authors:  Masakiyo Yatomi; Takeshi Hisada; Tamotsu Ishizuka; Yasuhiko Koga; Akihiro Ono; Yosuke Kamide; Kaori Seki; Haruka Aoki-Saito; Hiroaki Tsurumaki; Noriaki Sunaga; Kyoichi Kaira; Kunio Dobashi; Masanobu Yamada; Fumikazu Okajima
Journal:  Physiol Rep       Date:  2015-12

10.  BML-111 suppresses TGF-β1-induced lung fibroblast activation in vitro and decreases experimental pulmonary fibrosis in vivo.

Authors:  Yu-Dong Ji; Zhen-Long Luo; Chun-Xiu Chen; Bo Li; Jie Gong; Ya-Xin Wang; Lin Chen; Shang-Long Yao; You Shang
Journal:  Int J Mol Med       Date:  2018-10-02       Impact factor: 4.101
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.